Parexel appoints Jim Anthony as CCO and President, Parexel Biotech
Anthony brings more than 25 years of pharmaceutical development and CRO experience to his expanded role
Anthony brings more than 25 years of pharmaceutical development and CRO experience to his expanded role
Astaxanthin is a powerful antioxidant and red-orange carotenoid pigment found in various aquatic organisms
Vivo Bio Tech will have end-to-end responsibility for conducting the full spectrum of pre-clinical safety and regulatory studies
Skyhawk Therapeutics enters into an option agreement to grant Merck KGaA, Darmstadt, Germany, exclusive global rights to drug candidates pursued under the collaboration upon option exercise
Projects 5X revenue growth by 2028, accelerates global market leadership and paves the way for IPO
Merck and mantro GmbH have established EdiMembre, Massachusetts, U.S.A., a Deep Tech spin-out in the alternative protein industry
OGSIVEO is the first and only therapy to receive marketing authorization in the EU for the treatment of desmoid tumors
The technology offers scalable continuous granulation at 200 kg/hour, with the potential to exceed 500 kg/hour for certain granules
The collaboration will combine Firstsource’s AI-first approach with Guidehealth’s expertise in value-based care innovation
Subscribe To Our Newsletter & Stay Updated